If you find this podcast useful please give it a rating and review on iTunes by clicking here
Top 5 Most Read RNS's on Vox Markets for Tuesday 4th October 2022
5. N4 Pharma PLC #N4P Double siRNA Testing Update
Announce successful in vitro testing of Nuvec® loaded with two small interfering RNA (siRNA) probes.
4. Poolbeg Pharma PLC #POLB POLB 001 US Patent update
The US Patent and Trademarks Office, after reviewing a patent application that is directed to the use of POLB 001 and its homologues for the treatment of hypercytokinemia (or "cytokine storm"), has indicated to the Company that the main claim is allowable.
3. Union Jack Oil PLC #UJO US$10m Net Revenues Landmark Reached at Wressle
Announce that material landmark net revenues of US$10,000,000 have been achieved from the Wressle hydrocarbon development, located within licences PEDL180 and PEDL182 in North Lincolnshire on the western margin of the Humber Basin.
Union Jack holds a 40% economic interest in this development.
2. Deepverge PLC #DVRG Labskin contract
Labskin contract to develop revolutionary new approach to testing for radiation exposure. Collaboration with team of experts to develop new standards to protect military and civilians working or living near radiation sources. In a 3-year project worth $810k to the Company.
1. Synairgen plc #SNG Data from the US NIH-led ACTIV-2 Phase 2 trial
Synairgen announces positive data from the US NIH-led ACTIV-2 Phase 2 trial for SNG001 in home-based participants with COVID-19